Wird geladen...
Intratumoral immunosuppression profiles in 11q‐deleted neuroblastomas provide new potential therapeutic targets
High‐risk neuroblastoma (NB) patients with 11q deletion frequently undergo late but consecutive relapse cycles with fatal outcome. To date, no actionable targets to improve current multimodal treatment have been identified. We analyzed immune microenvironment and genetic profiles of high‐risk NB cor...
Gespeichert in:
| Veröffentlicht in: | Mol Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7858123/ https://ncbi.nlm.nih.gov/pubmed/33252831 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12868 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|